Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA9159 in Seasonal Allergic Rhinitis
NCT05234580Phase 2Completed
- Sponsor
- Anhui Palo Alto Pharmaceuticals
- Start
- Apr 2022
- Primary completion
- Oct 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of pa9159 in seasonal allergic rhinitis (SAR), sponsored by Anhui Palo Alto Pharmaceuticals. Started Apr 2022; status: completed.
02
Drugs
pa9159
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT05234580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05234580.